We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-0.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$3.91B
AUM Growth
+$545M
Cap. Flow
+$210M
Cap. Flow %
5.36%
Top 10 Hldgs %
40.38%
Holding
2,228
New
603
Increased
482
Reduced
356
Closed
557

Sector Composition

Rank Sector Weight
1 Financials 9.4%
2 Technology 6.32%
3 Consumer Discretionary 5.14%
4 Industrials 4.27%
5 Communication Services 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
1251
PUT
Citigroup
C
$227B
$232K 0.01%
+3,300
New +$231K
CHRS icon
1252
Coherus Oncology
CHRS
$192M
$232K 0.01%
14,427
-327
-2% -$4.79K
FLXN
1253
DELISTED
Flexion Therapeutics, Inc.
FLXN
$232K 0.01%
38,000
+1,700
+5% +$10.6K
MMYT icon
1254
MakeMyTrip
MMYT
$5.73B
$231K 0.01%
8,500
-13,500
-61% -$365K
POWW icon
1255
CALL
Outdoor Holding Co
POWW
$297M
$231K 0.01%
+37,500
New +$270K
PROV icon
1256
Provident Financial
PROV
$113M
$231K 0.01%
+13,694
New +$235K
INCY icon
1257
Incyte
INCY
$24.6B
$230K 0.01%
3,350
-1,195
-26% -$90.8K
JBLU icon
1258
JetBlue
JBLU
$2.13B
$229K 0.01%
+14,967
New +$230K
LI icon
1259
CALL
Li Auto
LI
$12.6B
$229K 0.01%
+8,700
New +$262K
NCNO icon
1260
nCino
NCNO
$2.08B
$229K 0.01%
+3,217
New +$214K
ISBC
1261
DELISTED
Investors Bancorp, Inc.
ISBC
$229K 0.01%
15,187
-91,003
-86% -$1.27M
AUPH icon
1262
CALL
Aurinia Pharmaceuticals
AUPH
$2.06B
$228K 0.01%
+10,300
New +$163K
TRIL
1263
CALL
DELISTED
Trillium Therapeutics Inc.
TRIL
$228K 0.01%
+13,000
New +$152K
RVLV icon
1264
Revolve Group
RVLV
$1.73B
$227K 0.01%
3,675
+197
+6% +$12.8K
JMIA
1265
PUT
Jumia Technologies
JMIA
$743M
$225K 0.01%
12,100
+400
+3% +$8.46K
MODN
1266
DELISTED
MODEL N, INC.
MODN
$225K 0.01%
+6,704
New +$226K
BNR
1267
Burning Rock Biotech
BNR
$115M
$224K 0.01%
1,250
-66
-5% -$14.7K
IWN icon
1268
PUT
iShares Russell 2000 Value ETF
IWN
$14.5B
$224K 0.01%
+1,400
New +$225K
LNN icon
1269
Lindsay Corp
LNN
$1.17B
$224K 0.01%
1,474
-5,649
-79% -$912K
PBW icon
1270
PUT
Invesco WilderHill Clean Energy ETF
PBW
$458M
$224K 0.01%
+2,900
New +$237K
TAOX
1271
Tao Synergies Inc
TAOX
$26.1M
$223K 0.01%
899
+353
+65% +$72.5K
V icon
1272
PUT
Visa
V
$675B
$223K 0.01%
+1,000
New +$234K
SILJ icon
1273
Amplify Junior Silver Miners ETF
SILJ
$3.95B
$222K 0.01%
18,830
-51,848
-73% -$695K
ADPT icon
1274
Adaptive Biotechnologies
ADPT
$4.05B
$221K 0.01%
6,489
-1,361
-17% -$49.2K
LPX icon
1275
Louisiana-Pacific
LPX
$5.2B
$221K 0.01%
3,609
-6,985
-66% -$412K

Similar funds

Prelude Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Prelude Capital Management held 2,228 positions worth $3.91B, up 16% from $3.36B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management deployed $210M of net new capital in Q3 2021, opening 603 new positions and adding to 482 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.

By sector, the portfolio is most concentrated in Financials at 9.4% of assets, up from 8.9% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Frontier Communications, an estimated $8.65M trimmed.

  • Prelude Capital Management's largest Q3 2021 buy was Vanguard S&P 500 ETF: 208,151 shares worth $82.1M.
  • Prelude Capital Management added most to Valaris in Q3 2021, an estimated $24.1M increase.
  • Prelude Capital Management's biggest Q3 2021 reduction was Frontier Communications, cutting an estimated $8.65M.
  • Prelude Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $22.9M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $3.91B portfolio in Q3 2021.
  • Prelude Capital Management opened 603 new positions and closed 557 in Q3 2021.
  • Prelude Capital Management's portfolio value rose 16% quarter-over-quarter to $3.91B.

Based on Prelude Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.